PALO ALTO, Calif., March 11, 2020 /CNW/ -- Varian (NYSE: VAR)
today announced that the procurement representative of the
Quebec government, Groupe
d'Approvisionnement Commun de l'Est du Québec (GACEQ), filed a
notice of intent to award a sole source contract to Varian for an
order of 12 medical linear accelerators (linacs). This award,
combined with the nine new Varian linacs coming to the new CHU de
Quebec cancer center, makes a
total of 21 Varian linacs purchased over the last four years in
Quebec. The 12 new linacs will be
booked in accordance with purchase orders being issued for the
individual systems.
The GACEQ selection represents new Varian
TrueBeam® systems in Rimouski, Chicoutimi, Gatineau, Jewish General Hospital,
Trois-Rivieres, and the new Cancer
Centre in Abitibi. The majority of these systems will also be
equipped with HyperArc™ to potentially expand access to
stereotactic radiosurgery (SRS), an advanced form of cancer
treatment.
"We are honored GACEQ selected Varian as its partner to bring
these advanced treatments to more patients in Quebec," said Chris
Toth, president Varian Oncology Systems. "Varian believes
that, to create a world without fear of cancer, you must increase
access to care. We look forward to working closely with our
clinical partners in Quebec to
install these new systems to provide more patients in Quebec the advanced care they require."
The TrueBeam family of medical linear accelerators incorporates
numerous technical innovations that dynamically synchronize
imaging, patient positioning, motion management, and treatment
delivery during a radiotherapy or radiosurgery procedure.
The HyperArc solution is designed to automate and simplify
sophisticated treatments such as SRS and capitalizes on the unique
capabilities of Varian's TrueBeam systems. HyperArc treatments
allow clinicians the ability to deliver more compact radiation
doses that closely conform to the size, shape, and location of
tumors, while sparing more surrounding healthy tissue. These
advanced treatments can be delivered in a typical treatment time
slot.
About Varian
At Varian, we envision a world without fear of cancer. For more
than 70 years, we have developed, built and delivered innovative
cancer care technologies and solutions for our clinical partners
around the globe to help them treat millions of patients each year.
With an Intelligent Cancer Care approach, we are harnessing
advanced technologies like artificial intelligence, machine
learning and data analytics to enhance cancer treatment and expand
access to care. Our 10,000 employees across 70 locations keep the
patient and our clinical partners at the center of our thinking as
we power new victories in cancer care. Because, for cancer patients
everywhere, their fight is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark
Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/quebec-selects-varian-to-increase-access-to-advanced-cancer-care-301021005.html
SOURCE Varian